The airway stent market has seen considerable growth due to a variety of factors.
• The airway stent market will grow from $9.98 billion in 2024 to $10.73 billion in 2025 at a CAGR of 7.5%.
The growth is attributed to the rising incidence of respiratory diseases, improved diagnostic techniques, an aging population, better healthcare access, and the growth in surgical and interventional procedures.
The airway stent market is expected to maintain its strong growth trajectory in upcoming years.
• The airway stent market is expected to reach $14.2 billion by 2029, growing at a CAGR of 7.3%.
The growth is due to an aging population, improved healthcare infrastructure, rising emphasis on managing chronic respiratory conditions, and growth in outpatient procedures. Trends include technological advancements, minimally invasive procedures, advancements in medical technology, bioresorbable stents, and self-expanding materials.
The rising prevalence of lung diseases and respiratory disorders is expected to drive the growth of the airway stent market. The increasing number of these conditions is linked to pollution, smoking, and the aging population. Airway stents are used to improve airflow and provide support to airways in patients with conditions like tracheal stenosis. For instance, in May 2024, the National Center for Health Statistics reported a rise in asthma prevalence and episodes in the U.S. The growing incidence of lung diseases is stimulating the airway stent market.
The airway stent market covered in this report is segmented –
1) By Type: Tracheal Stents, Laryngeal Stents, Bronchial stents
2) By Product Type: Expandable Stents, Non-Expandable Stents
3) By Material Type: Metal, Silicone, Hybrid
4) By End-User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Laboratories, Research Facilities
Subsegments:
1) By Tracheal Stents: Silicone Tracheal Stents, Metallic Tracheal Stents, Hybrid Tracheal Stents
2) By Laryngeal Stents: Silicone Laryngeal Stents, Self-Expanding Laryngeal Stents, Biodegradable Laryngeal Stents
3) By Bronchial Stents: Metallic Bronchial Stents, Silicone Bronchial Stents, Covered Bronchial Stents, Self-Expanding Bronchial Stents
Companies in the airway stent market are focusing on technological innovations like self-expanding Y-shaped stents to improve patient outcomes for complex airway conditions. For example, in February 2022, Micro-Tech Endoscopy, a US-based company, launched the first self-expanding tracheobronchial nitinol Y-stent. This device is designed to support airway patency in patients with tracheal or bronchial stenosis, offering features like a low-profile delivery system and repositioning sutures for easy adjustment.
Major companies operating in the airway stent market are:
• Medtronic Plc
• Stryker Corporation
• Boston Scientific Corporation
• Olympus Corporation
• Teleflex Incorporated
• Cook Medical
• KARL STORZ SE & Co. KG
• Merit Medical Systems
• MICRO-TECH (Nanjing) Co. Ltd.
• Taewoong Medical Co. Ltd.
• Alvimedica Medical Technologies Inc
• M.I. Tech Co. Ltd.
• Fuji Systems Corporation
• Pnn Medical A/S
• Endo-Flex GmbH
• InSitu Technologies
• QualiMed Innovative Medizinprodukte GmbH
• Novatech SA
• Boston Medical Products Inc.
• HOOD LABORATORIES
• Meditek Systems Pvt. Ltd.
• Kapitex Healthcare Ltd
• S&G Biotech Inc.
• AndraTec GmbH
• Allium Medical Solutions Ltd.
• Medi-Globe GmbH
• Bess medizintechnik GmbH
North America was the largest region in the airway stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the airway stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.